Jul 2026· Nanomedicine: Nanotechnology, Biology and Medicine· Vol 76, pp.
102995
· 0 citations· 60 references
Medicine
TL;DR
Findings support mitochondrial preservation as a key mechanism underlying nanoceria-mediated retinal neuroprotection and highlight CeO2-NPs as promising candidates for maintaining retinal homeostasis in AMD.
Abstract
Age-related Macular Degeneration (AMD), the leading cause of blindness worldwide, is a multifactorial disease with mitochondrial dysfunction recognized as an early pathogenic event. In our preclinical studies, we demonstrated that a single Cerium-Oxide Nanoparticles (CeO2-NPs) intravitreal injection in a light-induced degeneration model, was able to counteract the retinal degeneration. Our aim was to investigate whether neuroprotection activity could be correlated with mitochondrial morpho-functional preservation. Bulk transcriptomic profiling of whole retinal tissue revealed that light-induced retinal injury was associated with suppression of mitochondrial-related gene networks, including components of the electron transport chain and regulators of mitochondrial dynamics, whereas CeO2-NPs treatment restored the expression of antioxidant and mitochondrial biogenesis-related genes. Ultrastructural analysis by electron microscopy showed preservation of Retinal Pigmented Epithelial mitochondria's morphology and by high-resolution crystallographic analysis confirmed the intracellular localization of CeO2-NPs in proximity to mitochondria. Furthermore, Western blot analysis demonstrated that CeO2-NPs maintained mitophagy markers at basal levels, preventing excessive activation of mitochondrial quality-control pathways. Together, these findings support mitochondrial preservation as a key mechanism underlying nanoceria-mediated retinal neuroprotection and highlight CeO2-NPs as promising candidates for maintaining retinal homeostasis in AMD.
Current evidence supporting ferroptosis-related vulnerability in retinal neurodegenerative diseases is synthesized and emerging enabling strategies are evaluated, including nanocarrier-based delivery, long-acting gene modulation, and biomarker frameworks integrating ocular fluids, imaging, multi-omics, and artificial i...
Guang-Guang Wu, Su-Yu Wang, Zi-Yi Chen et al.· Frontiers in Medicine· 0 citations
The mitochondrial, redox, inflammatory, and neurovascular mechanisms proposed for PBM are examined, and preclinical and clinical evidence across nonexudative AMD, inherited retinal degeneration, diabetic retinal disease, and light-induced damage is discussed.
M. Toro, Alessandro Avitabile, Roberta Amato et al.· Antioxidants· 0 citations
Lipid peroxidation is established as mechanism of vision loss in NAION, and targeting GPX4 leads to neuroprotection and visual restoration and identifies GPX4 as a key molecular determinant of retinal ganglion cell resilience.
Ming Yang, Jie Pan, Shweta Modgil et al.· bioRxiv· 0 citations
Smart supramolecular Cerium-Rutin nanoparticles are developed for coordinated redox and immunomodulatory therapy in retinal detachment, providing a promising nanotherapeutic approach for the treatment of RD and other oxidative stress-associated neurodegenerative diseases.
Feiyu Jin, Weicheng Shen, Min Ren et al.· Journal of Controlled Releas...· 0 citations
APS protects photoreceptors against acute hypoxic injury through a multi-target mechanism modulating oxidative stress, mitochondrial stabilization, dual apoptosis inhibition, and autophagy activation, with a concentration-dependent safety profile, but its benefit is limited under prolonged hypoxia.
This study suggests that these DAMD cybrids do not fully recapitulate DAMD mitochondrial pathology, though this is limited to the study population of males with the H mtDNA haplogroup, however, there may be a niche for cybrid cell lines in investigating mitochondrial DNA phenotypes in patients with DAMD.
Jacob Dohl, Nyan Lin Zaw, Jett Nguyen et al.· Molecular Vision· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.